Palo Alto Investors »

Elevation Oncology shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.9M 1.8M 2.70
2024-03-31 $6.9M 1.3M 5.13

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
BioMarin Pharmaceutical (BMRN)
Amicus Therapeutics (FOLD)
United Therapeutics Corporation (UTHR)
Biogen Idec (BIIB)
Staar Surgical Com Par $0.01 (STAA)
Alnylam Pharmaceuticals Inc Note 1.000 9/1
ACADIA Pharmaceuticals (ACAD)
Prothena Corp SHS (PRTA)
Sarepta Therapeutics (SRPT)
Anaptysbio Inc Common (ANAB)
Iovance Biotherapeutics (IOVA)
Revance Therapeutics (RVNC)
Alkermes SHS (ALKS)
Sage Therapeutics (SAGE)

View all positions for Palo Alto Investors

Top funds holding Elevation Oncology

Logos Global Management
Farallon Capital Management
Tang Capital Management
Frazier Life Sciences Management
Aisling Capital Management
BlackRock
Balyasny Asset Management
Braidwell
venBio Partners
Hudson Bay Capital Management
BVF
Vanguard Group
Darwin Global Management
Palo Alto Investors
Point72 Asset Management

View all funds holding Elevation Oncology